France's IMPLANET Q1 revenue rises as U.S. medical equipment business expands

Implanet SA

14/04/2026 17:07

Overview

France medical implants maker's Q1 2026 revenue rose 18% yr/yr to €3.03 mln

Q1 U.S. revenue jumped 167%, driven by medical equipment distribution expansion

Spine implant sales declined 4% as company transitions to new hybrid fixation system

Outlook

IMPLANET plans to strengthen its U.S. presence by expanding its sales force and scientific team

Company aims to expand product rollout in France, the U.S., and China, including JSS and JAZZ®

IMPLANET to launch SMTP aspiration range, entering surgical revision and tumor surgery markets

Result Drivers

MEDICAL EQUIPMENT EXPANSION - Revenue growth driven by expansion of medical equipment distribution, especially the SMTP ultrasonic scalpel

U.S. SALES SURGE - U.S. revenue rose 167% in Q1 2026, attributed to strong expansion of medical equipment distribution

EXPORT MARKET SLOWDOWN - Revenue in rest of world declined 19% due to deferred orders from Middle East and Asia amid financial risk management

Company press release: ID:nBw6rfHZ8a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 3.03 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)